• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁:阿尔茨海默病氧化应激的氧化还原活性中心。

Iron: the Redox-active center of oxidative stress in Alzheimer disease.

作者信息

Castellani Rudy J, Moreira Paula I, Liu Gang, Dobson Jon, Perry George, Smith Mark A, Zhu Xiongwei

机构信息

Department of Pathology, University of Maryland, Baltimore, MD, USA.

出版信息

Neurochem Res. 2007 Oct;32(10):1640-5. doi: 10.1007/s11064-007-9360-7. Epub 2007 May 17.

DOI:10.1007/s11064-007-9360-7
PMID:17508283
Abstract

Although iron is essential in maintaining the function of the central nervous system, it is a potent source of reactive oxygen species. Excessive iron accumulation occurs in many neurodegenerative diseases including Alzheimer disease (AD), Parkinson's disease, and Creutzfeldt-Jakob disease, raising the possibility that oxidative stress is intimately involved in the neurodegenerative process. AD in particular is associated with accumulation of numerous markers of oxidative stress; moreover, oxidative stress has been shown to precede hallmark neuropathological lesions early in the disease process, and such lesions, once present, further accumulate iron, among other markers of oxidative stress. In this review, we discuss the role of iron in the progression of AD.

摘要

尽管铁对于维持中枢神经系统的功能至关重要,但它也是活性氧的重要来源。在包括阿尔茨海默病(AD)、帕金森病和克雅氏病在内的许多神经退行性疾病中都存在过量的铁积累,这增加了氧化应激与神经退行性过程密切相关的可能性。特别是AD与多种氧化应激标志物的积累有关;此外,在疾病过程早期,氧化应激已被证明先于标志性神经病理损伤出现,并且一旦出现这些损伤,除了其他氧化应激标志物外,还会进一步积累铁。在这篇综述中,我们讨论了铁在AD进展中的作用。

相似文献

1
Iron: the Redox-active center of oxidative stress in Alzheimer disease.铁:阿尔茨海默病氧化应激的氧化还原活性中心。
Neurochem Res. 2007 Oct;32(10):1640-5. doi: 10.1007/s11064-007-9360-7. Epub 2007 May 17.
2
The role of iron as a mediator of oxidative stress in Alzheimer disease.铁作为阿尔茨海默病氧化应激中介的作用。
Biofactors. 2012 Mar-Apr;38(2):133-8. doi: 10.1002/biof.1010. Epub 2012 Mar 23.
3
Alzheimer´s disease and oxidative stress: a review.阿尔茨海默病与氧化应激:综述。
Curr Med Chem. 2014;21(3):356-64. doi: 10.2174/09298673113206660258.
4
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals.阿尔茨海默病中神经原纤维缠结和老年斑的原位氧化催化作用:结合态过渡金属的核心作用
J Neurochem. 2000 Jan;74(1):270-9. doi: 10.1046/j.1471-4159.2000.0740270.x.
5
Oxidative stress and redox-active iron in Alzheimer's disease.阿尔茨海默病中的氧化应激与氧化还原活性铁
Ann N Y Acad Sci. 2004 Mar;1012:179-82. doi: 10.1196/annals.1306.015.
6
In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders.氧化应激标志物检测与定位的原位方法:在神经退行性疾病中的应用
Methods Enzymol. 1999;309:133-52. doi: 10.1016/s0076-6879(99)09012-6.
7
Oxidative stress, antioxidants, and Alzheimer disease.氧化应激、抗氧化剂与阿尔茨海默病
Alzheimer Dis Assoc Disord. 2000;14 Suppl 1:S62-6. doi: 10.1097/00002093-200000001-00010.
8
Early molecular changes in Alzheimer disease: can we catch the disease in its presymptomatic phase?阿尔茨海默病的早期分子变化:我们能否在疾病的无症状前期捕捉到它?
J Alzheimers Dis. 2014;38(4):719-40. doi: 10.3233/JAD-130920.
9
Evidence for a novel heme-binding protein, HasAh, in Alzheimer disease.阿尔茨海默病中一种新型血红素结合蛋白HasAh的证据。
Antioxid Redox Signal. 2000 Spring;2(1):137-42. doi: 10.1089/ars.2000.2.1-137.
10
Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.氧化还原活性铁和铜在阿尔茨海默病氧化损伤中的作用。
Ageing Res Rev. 2004 Jul;3(3):319-26. doi: 10.1016/j.arr.2004.01.002.

引用本文的文献

1
High Magnetic Property and Toxicity of Particulate Matter Generated during Welding and Cutting Processes.焊接和切割过程中产生的颗粒物的高磁性和毒性。
Environ Health (Wash). 2024 Mar 19;2(6):381-389. doi: 10.1021/envhealth.4c00021. eCollection 2024 Jun 21.
2
Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer's Disease.载脂蛋白 E4 在阿尔茨海默病发病机制中的氧化脂质代谢和铁死亡中的多种作用。
J Mol Neurosci. 2024 Jul 3;74(3):62. doi: 10.1007/s12031-024-02224-4.
3
Exosomal Dynamics and Brain Redox Imbalance: Implications in Alzheimer's Disease Pathology and Diagnosis.

本文引用的文献

1
The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development.阿尔茨海默病的细胞周期假说:药物研发建议
Biochim Biophys Acta. 2007 Apr;1772(4):503-8. doi: 10.1016/j.bbadis.2006.12.004. Epub 2006 Dec 13.
2
Detection, identification and mapping of iron anomalies in brain tissue using X-ray absorption spectroscopy.使用X射线吸收光谱法检测、识别和绘制脑组织中的铁异常。
J R Soc Interface. 2005 Mar 22;2(2):33-7. doi: 10.1098/rsif.2004.0011.
3
Neuropathology of Alzheimer disease: pathognomonic but not pathogenic.
外泌体动力学与脑氧化还原失衡:对阿尔茨海默病病理学及诊断的影响
Antioxidants (Basel). 2024 Mar 5;13(3):316. doi: 10.3390/antiox13030316.
4
Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer's Disease Causes a Functional Iron Deficiency That Advances Neurodegeneration.探索阿尔茨海默病患者中枢神经系统内的铁螯合是否会导致功能性铁缺乏,进而促进神经退行性变。
Brain Sci. 2023 Mar 18;13(3):511. doi: 10.3390/brainsci13030511.
5
The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer's Disease, Amyotrophic Lateral Sclerosis and Aging.新型多靶点铁螯合剂在阿尔茨海默病、肌萎缩侧索硬化症和衰老模型中的神经保护作用。
Cells. 2023 Feb 27;12(5):763. doi: 10.3390/cells12050763.
6
Understanding the mechanistic roles of environmental heavy metal stressors in regulating ferroptosis: adding new paradigms to the links with diseases.理解环境重金属应激源在调控铁死亡中的机制作用:为其与疾病的关联增添新范式。
Apoptosis. 2023 Apr;28(3-4):277-292. doi: 10.1007/s10495-022-01806-0. Epub 2023 Jan 7.
7
Senegenin Rescues PC12 Cells with Oxidative Damage Through Inhibition of Ferroptosis.Senegenin 通过抑制铁死亡来拯救氧化损伤的 PC12 细胞。
Mol Neurobiol. 2022 Nov;59(11):6983-6992. doi: 10.1007/s12035-022-03014-y. Epub 2022 Sep 7.
8
Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope.阿尔茨海默病中线粒体功能障碍的机制:新的治疗希望。
Oxid Med Cell Longev. 2022 May 14;2022:4759963. doi: 10.1155/2022/4759963. eCollection 2022.
9
Effects of Deferasirox in Alzheimer's Disease and Tauopathy Animal Models.去铁酮在阿尔茨海默病和 Tau 病动物模型中的作用。
Biomolecules. 2022 Feb 25;12(3):365. doi: 10.3390/biom12030365.
10
In vivo brain iron concentration in healthy individuals at 3.0 T magnetic resonance imaging: a prospective cross-sectional study.在 3.0T 磁共振成像中健康个体脑内铁浓度的活体研究:一项前瞻性的横断面研究。
Br J Radiol. 2022 May 1;95(1133):20210809. doi: 10.1259/bjr.20210809. Epub 2022 Feb 4.
阿尔茨海默病的神经病理学:具有诊断特征但并非致病原因。
Acta Neuropathol. 2006 Jun;111(6):503-9. doi: 10.1007/s00401-006-0071-y. Epub 2006 Apr 27.
4
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration.脑铁蛋白铁可能影响与年龄和性别相关的神经退行性变风险。
Neurobiol Aging. 2007 Mar;28(3):414-23. doi: 10.1016/j.neurobiolaging.2006.02.005. Epub 2006 Mar 24.
5
In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice.阿尔茨海默病转基因小鼠中单个淀粉样斑块的体内磁共振显微成像。
J Neurosci. 2005 Oct 26;25(43):10041-8. doi: 10.1523/JNEUROSCI.2588-05.2005.
6
In situ characterization and mapping of iron compounds in Alzheimer's disease tissue.阿尔茨海默病组织中铁化合物的原位表征与图谱分析。
J Alzheimers Dis. 2005 Aug;7(4):267-72. doi: 10.3233/jad-2005-7401.
7
Nanoparticle and other metal chelation therapeutics in Alzheimer disease.纳米颗粒及其他金属螯合疗法在阿尔茨海默病中的应用
Biochim Biophys Acta. 2005 Sep 25;1741(3):246-52. doi: 10.1016/j.bbadis.2005.06.006.
8
Therapeutic opportunities in Alzheimer disease: one for all or all for one?阿尔茨海默病的治疗机遇:一人一方还是千人千方?
Curr Med Chem. 2005;12(10):1137-47. doi: 10.2174/0929867053764644.
9
Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron.阿尔茨海默病中的核糖体RNA被结合的氧化还原活性铁氧化。
J Biol Chem. 2005 Jun 3;280(22):20978-86. doi: 10.1074/jbc.M500526200. Epub 2005 Mar 14.
10
Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease.挑战淀粉样蛋白级联假说:老年斑和β淀粉样蛋白作为对阿尔茨海默病的保护性适应。
Ann N Y Acad Sci. 2004 Jun;1019:1-4. doi: 10.1196/annals.1297.001.